ClassID:

94274

C07D215/26 - CPC Classification

Classification description:

Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Oxygen atoms attached in position 8 Alcohols; Ethers thereof

Sub-classes:
Recent Application in this class:
#1
20260109673
2026-04-23

ACETYL-COA CARBOXYLASE MODULATORS

#2
20260103444
2026-04-16

8-HYDROXYQUINOLINE COMPOUND AND USE THEREOF

#3
20250346563
2025-11-13

HISTONE DEACETYLASE 6 INHIBITORS AND METHOD FOR TREATING NEUROPATHIC PAIN

#4
20240287006
2024-08-29

E3 Ligase Inhibitors and Methods of Use Thereof

#5
20240140913
2024-05-02

A PROCESS FOR PREPARING ABEDITEROL AND INTERMEDIATES THEREOF

#6
20230382868
2023-11-30

NOVEL QUINOLIN-2-YL NITRONES USEFUL FOR THE PREVENTION AND/OR TREATMENT OF NEURODEGENERATIVE DISEASES

#7
20230295136
2023-09-21

Analogs of Nitrofuran Antibiotics to Combat Resistance

#8
20230107256
2023-04-06

Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereof

#9
20220306584
2022-09-29

HISTONE DEMETHYLASE INHIBITORS FOR TREATING CANCERS

#10
20220251043
2022-08-11

HISTONE DEACETYLASE 6 INHIBITORS AND METHOD FOR TREATING NEUROPATHIC PAIN

#11
20220009914
2022-01-13

Analogs of Nitrofuran Antibiotics to Combat Resistance

#12
20210363165
2021-11-25

Nitroxoline prodrug and use thereof

#13
20210276957
2021-09-09

NADPH oxidase inhibitors, pharmaceutical composition comprising the same, and application thereof

#14
20210246106
2021-08-12

ACETYL-COA CARBOXYLASE MODULATORS

#15
20210228535
2021-07-29

SMALL MOLECULES AGAINST CANCER

#16
20210155612
2021-05-27

α,β-unsaturated amide compound

#17
20210024468
2021-01-28

8-hydroxyquinoline derivatives as diagnostic and therapeutic agents

#18
20200268709
2020-08-27

Small molecules against cancer

#19
20200102274
2020-04-02

Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereof

#20
20200063182
2020-02-27

FLUOROPHORE-BASED KINASE SENSORS

#21
20190284141
2019-09-19

Histone deacetylase 6 inhibitors and use thereof

#22
20190270719
2019-09-05

Deoxyuridine triphosphatase inhibitors

#23
20190256471
2019-08-22

SMALL MOLECULE INHIBITORS OF BOTULINUM NEUROTOXINS

#24
20190240188
2019-08-08

Small molecules against cancer

#25
20190135757
2019-05-09

Acetyl-CoA carboxylase modulators

#26
20190031685
2019-01-31

HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF

#27
20190023659
2019-01-24

Process for the preparation of polyfluoroalkylated quinolines

#28
20180327362
2018-11-15

8-hydroxyquinoline derivatives as diagnostic and therapeutic agents

#29
20180305308
2018-10-25

Industrial process for the preparation of (5S, 10S)-10-benzyl-16-methyl-11, 14, 18-trioxo-15, 17, 19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium(E)-3-carboxyacrylate salt

#30
20180258028
2018-09-13

Process for the preparation of indanamine derivatives and new synthesis intermediates

#31
20180215714
2018-08-02

Process for preparing indacaterol and salts thereof

#32
20180155319
2018-06-07

Deoxyuridine triphosphatase inhibitors

#33
20170044107
2017-02-16

Inhibitors of JMJD2C as Anticancer Agents

#34
20170015628
2017-01-19

Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof

#35
20170008849
2017-01-12

Quinoline compounds

#36
20170000801
2017-01-05

Triarylmethane analogs and their use in treating cancers

#37
20160326118
2016-11-10

Process for preparation of indacaterol or its pharmaceutically acceptable salts

#38
20160271278
2016-09-22

Tau imaging probe

#39
20160264557
2016-09-15

Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities

#40
20160222001
2016-08-04

COMT inhibiting methods and compositions

#41
20160211468
2016-07-21

Metal complexes

#42
20160145212
2016-05-26

Acetyl CoA carboxylase modulators

#43
20160131648
2016-05-12

Alkyl quinolones as biomarkers of pseudomonas aeruginosa infection and uses thereof

#44
20160039788
2016-02-11

Deoxyuridine triphosphatase inhibitors

#45
20160008494
2016-01-14

Tau imaging probe

#46
20150336876
2015-11-26

Phenoxyalkylamine compound

#47
20150329535
2015-11-19

Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity

#48
20150225346
2015-08-13

Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof

#49
20150094334
2015-04-02

8-hydroxy quinoline derivatives

#50
20150072974
2015-03-12

D2 receptor modulators and methods of use thereof in the treatment of diseases and disorders

#51
20150065471
2015-03-05

SALTS OF 5-[(1R)-2-(AMINO)-1-HYDROXYETHYL]-8-HYDROXYQUINOLIN-2(1H)-ONE

#52
20150057256
2015-02-26

Polymorphic crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, heminapadisytlate as agonist of the β2 adrenergic receptor

#53
20150025108
2015-01-22

8-hydroxy quinoline derivatives

#54
20150025085
2015-01-22

Iron Chelators And Uses Thereof

#55
20150011769
2015-01-08

Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one via a novel intermediate

#56
20140364454
2014-12-11

METAL-CHELATING COMPOUNDS HAVING AT LEAST ONE POLYAMINO CHAIN

#57
20140343091
2014-11-20

BETA2-adrenoceptor agonists

#58
20140323302
2014-10-30

Process for the preparation of a quinoline carboxylic acid

#59
20140299856
2014-10-09

Organic electroluminescence element

#60
20140296251
2014-10-02

Multifunctional quinoline derivatives as anti-neurodegenerative agents

#61
20140194439
2014-07-10

Methods of targeted drug development

#62
20140186280
2014-07-03

NEUROPROTECTIVE AND NEURO-RESTORATIVE IRON CHELATORS AND MONOAMINE OXIDASE INHIBITORS AND USES THEREOF

#63
20140066478
2014-03-06

Beta2-adrenoreceptor agonists

#64
20140045793
2014-02-13

Quinolone compound and pharmaceutical composition

#65
20140038962
2014-02-06

Flavivirus inhibitors and methods of their use

#66
20130330284
2013-12-12

Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof

#67
20130324523
2013-12-05

Tau imaging probe

#68
20130303740
2013-11-14

Process for the preparation of urethanes

#69
20130281415
2013-10-24

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

#70
20130231367
2013-09-05

BETA2-adrenoreceptor agonists

#71
20130225610
2013-08-29

ANTIMETASTATIC COMPOUNDS

#72
20130217678
2013-08-22

PHARMACEUTICAL AGENT COMPRISING QUINOLONE COMPOUND

#73
20130131096
2013-05-23

8-hydroxy-quinoline derivatives

#74
20130053359
2013-02-28

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

#75
20130035348
2013-02-07

Antimetastatic compounds

#76
20130005767
2013-01-03

THERAPEUTIC COMPOUNDS

#77
20130005675
2013-01-03

Quinolone compound and pharmaceutical composition

#78
20120316142
2012-12-13

QUINOLINONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS

#79
20120302531
2012-11-29

Beta-2-adrenoreceptor agonists

#80
20120220775
2012-08-30

ENANTIOSELECTIVE PREPARATION OF QUINOLINE DERIVATIVES

#81
20120220626
2012-08-30

Quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease

#82
20120196853
2012-08-02

Novel Quinoline-Hepcidine Antagonists

#83
20120190847
2012-07-26

Triarylmethane analogs and their use in treating cancers

#84
20120142750
2012-06-07

INDOLEAMINE 2,3-DIOXYGENASE PATHWAYS IN THE GENERATION OF REGULATORY T CELLS

#85
20120142646
2012-06-07

Novel Compounds 621

#86
20120115826
2012-05-10

Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 AdrenergicReceptor

#87
20120108815
2012-05-03

Bifunctional/polyfunctional dopamine D2/D3 agonist as neuroprotective agents for treatment of neurodegenerative diseases

#88
20120101075
2012-04-26

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor

#89
20120077838
2012-03-29

Beta-2-adrenoreceptor agonists

#90
20120058945
2012-03-08

Neuroprotective iron chelators and pharmaceutical compositions comprising them

#91
20120040941
2012-02-16

5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AND ITS USE IN THE TREATMENT OF PULMONARY DISEASES

#92
20120004414
2012-01-05

Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one

#93
20110301193
2011-12-08

Methods and compositions of targeted drug development

#94
20110294848
2011-12-01

Small molecule inhibitors of botulinum neurotoxins

#95
20110269705
2011-11-03

Quinolone compound and pharmaceutical composition

#96
20110251238
2011-10-13

PPAR AGONIST COMPOSITIONS AND METHODS OF USE

#97
20110251234
2011-10-13

Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]jamino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor

#98
20110251180
2011-10-13

PHARMACEUTICAL AGENT COMPRISING QUINOLONE COMPOUND

#99
20110251166
2011-10-13

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptor

#100
20110251165
2011-10-13

DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR

#101
20110224242
2011-09-15

STYRLYQUINOLINES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC USES

#102
20110224207
2011-09-15

inhibitors and methods for their use

#103
20110195943
2011-08-11

NAPADISYLATE SALT OF 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE BETA 2 ADRENERGIC RECEPTOR

#104
20110178041
2011-07-21

HETEROCYCLIC BIARYL DERIVATIVE AND PDE INHIBITOR COMPRISING SAME AS ACTIVE INGREDIENT

#105
20110144069
2011-06-16

COMPOUNDS FOR TREATING VIRAL INFECTIONS

#106
20110118469
2011-05-19

Continuous flow synthesis of amino alcohols using microreactors

#107
20110112282
2011-05-12

IDO INHIBITORS AND THERAPEUTIC USES THEREOF

#108
20110059939
2011-03-10

Therapeutic compounds

#109
20110053977
2011-03-03

Small molecule E2F inhibitor

#110
20110053941
2011-03-03

IDO inhibitors

#111
20110053180
2011-03-03

Kinase sensors

#112
20110044913
2011-02-24

8-HYDROXY-5-[(1R)-1-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO]ETHYL]-2(1H)-QUINOLINONE HEMI-FUMARATE

#113
20110034509
2011-02-10

Beta-2-adrenoreceptor agonists

#114
20110033393
2011-02-10

Hydrazone Compounds and Their Use

#115
20110021561
2011-01-27

Quinoline compound and pharmaceutical composition, preparation method and uses thereof

#116
20100324000
2010-12-23

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptors

#117
20100304966
2010-12-02

Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same

#118
20100298358
2010-11-25

Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors

#119
20100280024
2010-11-04

RENIN INHIBITORS

#120
20100189762
2010-07-29

TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS

#121
20100160296
2010-06-24

Use of imipramine blue and analogs thereof in treating cancers

#122
20100152165
2010-06-17

CARBOXYLIC ACID DERIVATIVES

#123
20100152148
2010-06-17

NOVEL COMPOUNDS

#124
20100093681
2010-04-15

Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor

#125
20100056508
2010-03-04

AMINE DERIVATIVES AND THEIR USE IN BETA-2-ADRENORECEPTOR MEDIATED DISEASES

#126
20100048669
2010-02-25

Therapeutic compounds

#127
20100029705
2010-02-04

Beta-2-adrenoreceptor agonists

#128
20100010039
2010-01-14

POLYMORPHIC CRYSTAL FORM OF A INDAN-2-YLAMINO-HYDROXYETHYL-QUINOLINONE MALEATE DERIVATIVE AS BETA-ADRENOCEPTOR AGONIST

#129
20100004411
2010-01-07

Polymerisation of ethylene and α-olefins with imino-quinolinol complexes

#130
20090326231
2009-12-31

Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride

#131
20090325912
2009-12-31

Quinolinone derivatives and their pharmaceutical compositions

#132
20090295274
2009-12-03

Deuterated Semiconducting Organic Compounds for Use in Light-Emitting Devices

#133
20090280068
2009-11-12

POLYMORPH OF 8-HYDROXY-5-[(1R)-1-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO]ETHYL]-2(1H)-QUINOLINONE MONOHYDROCHLORIDE

#134
20090253739
2009-10-08

Amine Derivatives

#135
20090247758
2009-10-01

Quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease

#136
20090247637
2009-10-01

Anthranilic acid derivatives

#137
20090227625
2009-09-10

CXCR2 inhibitors

#138
20090227547
2009-09-10

Novel salt form of a Beta2-adrenergic agonist quinolin-2-one derivative

#139
20090182010
2009-07-16

COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY

#140
20090181943
2009-07-16

Inhibitors of histone deacetylase

#141
20090176745
2009-07-09

TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS

#142
20090155311
2009-06-18

INDOLEAMINE 2,3-DIOXYGENASE PATHWAYS IN THE GENERATION OF REGULATORY T CELLS

#143
20090143365
2009-06-04

Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors

#144
20090137393
2009-05-28

2,4,6-trialkylphenyl substituted cyclopentane-1,3-dione

#145
20090111850
2009-04-30

Amino-substituted ethylamino βadrenergic receptor agonists

#146
20090105203
2009-04-23

COMPOUNDS FOR TREATING VIRAL INFECTIONS

#147
20090093485
2009-04-09

Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases

#148
20090054653
2009-02-26

ENANTIOSELEKTIVE PREPARATION OF QUINOLINE DERIVATIVE

#149
20090054482
2009-02-26

Method of making and administering quinoline derivatives as anti-cancer agents

#150
20090042933
2009-02-12

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor

#151
20080300269
2008-12-04

Therapeutic compounds

#152
20080280849
2008-11-13

Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic Agents

#153
20080269213
2008-10-30

8-hydroxyquinoline compounds and methods thereof

#154
20080207573
2008-08-28

COMPOUNDS FOR TREATING VIRAL INFECTIONS

#155
20080161353
2008-07-03

8-hydroxy quinoline derivatives

#156
20080125462
2008-05-29

Cinnamate Salts Of A Beta-2 Adrenergic Agonist

#157
20080119538
2008-05-22

Therapeutic compounds

#158
20080113981
2008-05-15

Diaryl ether βadrenergic receptor agonists

#159
20080113975
2008-05-15

THIOUREA COMPOUNDS

#160
20080096875
2008-04-24

THIOUREA COMPOUNDS

#161
20080070880
2008-03-20

Glucocorticosteroid compound having anti-inflammatory activity

#162
20080039495
2008-02-14

Diamine Beta2 Adrenergic Receptor Agonists

#163
20080021231
2008-01-24

Novel compounds

#164
20080015360
2008-01-17

Compounds

#165
20080015231
2008-01-17

Therapeutic compounds

#166
20080009518
2008-01-10

5-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor Antagonists

#167
20070293561
2007-12-20

Therapeutic compounds

#168
20070281944
2007-12-06

Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom

#169
20070265303
2007-11-15

Amine derivatives for the treatment of asthma and COPD

#170
20070225365
2007-09-27

CETP inhibitors

#171
20070225329
2007-09-27

Aryl aniline βadrenergic receptor agonists

#172
20070197586
2007-08-23

8-Hydroxy-5-[(-Hydroxy-2-[[ (1R)-2-(4-Methoxyphenyl)-1-Methylethyl] Amino][Ethyl]-2(1H)-Quinolinone Monohydrochloride In Crystalline Form And The Process For Its Preparation

#173
20070123708
2007-05-31

Process for the synthesis of quinoline derivatives

#174
20070092467
2007-04-26

Oxyacetamide compounds useful for stimulating or inducing the growth and/or retarding the loss of keratin fibers

#175
20070043007
2007-02-22

Specific glucocorticosteroid compound having anti-inflammatory activity

#176
20070027141
2007-02-01

Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors

#177
20060293334
2006-12-28

Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase

#178
20060281810
2006-12-14

Novel anthranilic acid derivatives

#179
20060252794
2006-11-09

Process for preparing 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1H)-quinolin-2-one salt, useful as an andrenoceptor agonist

#180
20060247254
2006-11-02

Cyclopentapyridine and tetrahydroquinoline derivatives

#181
20060247219
2006-11-02

Specific glucocorticosteroid compound having anti-inflammatory activity

#182
20060234927
2006-10-19

Neuroprotective iron chelators and pharmaceutical compositions comprising them

#183
20060205794
2006-09-14

Phenethanolamine derivative for the treatment of respiratory diseases

#184
20060205712
2006-09-14

Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom

#185
20060189654
2006-08-24

Compounds

#186
20060189653
2006-08-24

Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones

#187
20060178410
2006-08-10

Aryl aniline β2 adrenergic receptor agonists

#188
20060167046
2006-07-27

Histamine h3 receptor antagonists, preparation and therapeutic uses

#189
20060160894
2006-07-20

Benzamides as ppar modulators

#190
20060116398
2006-06-01

Compounds having βadrenergic receptor agonist and muscarinic receptor antagonist activity

#191
20060111344
2006-05-25

Arylethanolamine β-adrenoreceptor agonist compounds

#192
20060100282
2006-05-11

Novel diaminopropane-based metal chelators as antiviral agents

#193
20060094755
2006-05-04

Novel quinoline-based metal chelators as antiviral agents

#194
20060089380
2006-04-27

8-hydroxy quinoline derivatives

#195
20060063843
2006-03-23

Compounds for the treatment of inflammatory disorders

#196
20060058530
2006-03-16

Amidine substituted aryl aniline compounds

#197
20060019991
2006-01-26

Diaryl ether β2 adrenergic receptor agonists

#198
20050277632
2005-12-15

Beta agonists for the treatment of respiratory diseases

#199
20050272769
2005-12-08

Diamine βadrenergic receptor agonists

#200
20050192316
2005-09-01

Aryl aniline βadrenergic receptor agonists

#201
20050153957
2005-07-14

β2-adrenoceptor agonists

#202
20050137210
2005-06-23

Substituted n-aryl amidines as selective D dopamine receptor antagonists for the treatment of obesity and CNS disorders

#203
20050113411
2005-05-26

Amino-substituted ethylamino βadrenergic receptor agonists

#204
20050080243
2005-04-14

Fluorescence assay for kinase activity

#205
20050080242
2005-04-14

Fluorescence assay for kinase activity

#206
20050043300
2005-02-24

Piperazine derivatives

#207
15820146
2020-04-28

Luminescent polydentate polycyclic compounds for metal ions

#208
14012701
2017-11-21

Luminescent polydentate polycyclic compounds for metal ions